No abstract available
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / pharmacology*
-
Carcinoma, Pancreatic Ductal / drug therapy*
-
Carcinoma, Pancreatic Ductal / enzymology*
-
Carcinoma, Pancreatic Ductal / pathology
-
Cell Growth Processes / drug effects
-
Drug Synergism
-
Heterocyclic Compounds, 3-Ring / administration & dosage
-
Heterocyclic Compounds, 3-Ring / pharmacology
-
Humans
-
MAP Kinase Kinase Kinases / antagonists & inhibitors*
-
MAP Kinase Kinase Kinases / metabolism
-
Morpholines / pharmacology
-
Pancreatic Neoplasms / drug therapy*
-
Pancreatic Neoplasms / enzymology*
-
Pancreatic Neoplasms / pathology
-
Phosphatidylinositol 3-Kinases / metabolism
-
Phosphoinositide-3 Kinase Inhibitors*
-
Protein Kinase Inhibitors / administration & dosage
-
Protein Kinase Inhibitors / pharmacology*
-
Pyridones / administration & dosage
-
Pyridones / pharmacology
-
Pyrimidinones / administration & dosage
-
Pyrimidinones / pharmacology
-
Triazines / pharmacology
Substances
-
Heterocyclic Compounds, 3-Ring
-
MK 2206
-
Morpholines
-
Phosphoinositide-3 Kinase Inhibitors
-
Protein Kinase Inhibitors
-
Pyridones
-
Pyrimidinones
-
Triazines
-
trametinib
-
gedatolisib
-
MAP Kinase Kinase Kinases